Taking a quite different approach to that of other firms in similar space, DNA Medicine Institute, Inc (DMI) is a medical device company addressing the seamless merging of science and engineering - leveraging an in-depth background in interdisciplinary science to achieve innovative commercial solutions. Describing themselves as a med-tech incubator, laboratory, and biomedical technology service provider, the firm is primarily focused on advancing the rHEALTH diagnostic technology, designed to provide multiple lab values off a single drop of blood. The firm's the rHEALTH technology is being developed for NASAs upcoming mission to Mars effectively to provide comprehensive biomedical analysis for crew members. The firm's developed pPoducts are marketed through partner organizations, either spin-outs from DMI or partner market-facing companies. DNA's e rHEALTH won the XPRIZEs Nokia Sensing XChallenge and was a Finalist in the Qualcomm Tricorder XPRIZE.
